Your browser doesn't support javascript.
loading
Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinoma.
Steven, André; Leisz, Sandra; Fussek, Sebastian; Nowroozizadeh, Behdokht; Huang, Jiaoti; Branstetter, Daniel; Dougall, William C; Burchardt, Martin; Belldegrun, Arie S; Seliger, Barbara; Pantuck, Allan; Kroeger, Nils.
Afiliação
  • Steven A; Institute of Medical Immunology at the Martin Luther University Halle/Wittenberg, Halle, Germany.
  • Leisz S; Institute of Medical Immunology at the Martin Luther University Halle/Wittenberg, Halle, Germany.
  • Fussek S; Department of Urology, University Medicine at the Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany.
  • Nowroozizadeh B; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at the University of California, Los Angeles, CA.
  • Huang J; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at the University of California, Los Angeles, CA.
  • Branstetter D; Department of Hematology and Oncology Research, Amgen Inc., Seattle, WA.
  • Dougall WC; Department of Hematology and Oncology Research, Amgen Inc., Seattle, WA.
  • Burchardt M; Department of Urology, University Medicine at the Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany.
  • Belldegrun AS; Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at the University of California, Los Angeles, CA.
  • Seliger B; Institute of Medical Immunology at the Martin Luther University Halle/Wittenberg, Halle, Germany.
  • Pantuck A; Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at the University of California, Los Angeles, CA.
  • Kroeger N; Department of Urology, University Medicine at the Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany; Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at the University of California, Los Angeles, CA; Institute of Medical Biochemistry and Molecular Me
Urol Oncol ; 36(11): 502.e15-502.e24, 2018 11.
Article em En | MEDLINE | ID: mdl-30170981
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Ligante RANK / Receptor Ativador de Fator Nuclear kappa-B / Neoplasias Renais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Ligante RANK / Receptor Ativador de Fator Nuclear kappa-B / Neoplasias Renais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article